Severe immune thrombocytopenia in a critically ill COVID-19 patient

Abstract

The novel coronavirus SARS-CoV-2 can cause a severe and even fatal respiratory illness named COVID-19. Apart from respiratory failure, COVID-19 may be associated with various autoimmune complications. We present a case of a critically ill patient with COVID-19 who developed severe immune thrombocytopenia that was successfully treated with a concomitant use of corticosteroids and intravenous immunoglobulins.

Keywords

• COVID-19
• SARS-CoV-2
• immune thrombocytopenia
• corticosteroids
• intravenous immunoglobulins